Magnitude of chronic kidney disease in Spain
Saved in:
| Main Authors: | Rafael Santamaria, Carlos Escobar, Unai Aranda, Beatriz Palacios, Margarita Capel, Ignacio Hernández, Ana Cebrián, Roberto Alcázar, Manuel Gorostidi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-05-01
|
| Series: | Nefrología (English Edition) |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2013251425000604 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Magnitude of chronic kidney disease in Spain
by: Rafael Santamaria, et al.
Published: (2025-05-01) -
Projection of the clinical and economic burden of chronic kidney disease between 2022 and 2027 in Spain: Results of the Inside CKD project
by: Juan F. Navarro González, et al.
Published: (2024-11-01) -
Evaluation of clinical events and costs associated with the addition of dapagliflozin to chronic kidney disease treatment: Cost offset analysis
by: Juan Francisco Navarro-González, et al.
Published: (2024-11-01) -
Cost-utility analysis of dapagliflozin for the treatment of symptomatic chronic heart failure in Spain
by: Carlos Escobar, et al.
Published: (2025-07-01) -
High Prevalence of Unrecorded Stage 3 Chronic Kidney Disease in Australia, Brazil, Canada, England, and Spain: The Multinational, Observational REVEAL-CKD Study
by: Roberto Pecoits-Filho, et al.
Published: (2024-01-01)